Skip to main content
Premium Trial:

Request an Annual Quote

NRGene Completes $30.6M IPO

NEW YORK – NRGene said Tuesday that it has completed its initial public offering on the Tel Aviv Stock Exchange, raising approximately NIS 100 million ($30.6 million). The IPO values the Israeli company at NIS 370 million.

Herzog Fox & Neeman and PwC Israel advised the company on the IPO.

NRGene, based in Ness Ziona, Israel, develops artificial intelligence technologies to analyze agricultural and livestock genomic data. Products include DeNovoMax software for assembling reference-level genomes for use in breeding and agriculture.

"Going public is a significant milestone in the company's plan for growth," NRGene Chairman Asaf Levi said in a statement. He said that the firm would apply the new funding to support growth and form long-term collaborations with breeding companies.

"The company currently plans to expand its global activities and become an integral part of the optimization processes in agriculture and the food industry," added CEO and Cofounder Gil Ronen. "We estimate that in the near future NRGene will become a key player in this highly important and growing field."

Existing customers include Bayer and Syngenta, according to NRGene. The firm adopted a new business model last year that involves joint development of intellectual property in return for royalties from sales of associated products. 

The Scan

Billion-Dollar Diversity Initiative

The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce.

Biotech Co-Founder Arrested

A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News.

Return of the Tasmanian Tiger

The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction.

Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More

In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.